Daniel W. Jones

HYPERTENSION · 2003–2017

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts Daniel W. Jones

  1. S. Hyman (in Cardiology and Cardiovascular Medicine)

Papers from Daniel W. Jones's perspective

Ordered by how strongly the researchers Daniel W. Jones trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
  2. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
  3. Response to Letter to editor "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults". (Journal of the American Society of Hypertension : JASH)
  4. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. (Kidney International)
  5. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. (Journal of the American Medical Association (JAMA))
  6. Effect of lipid reduction on the progression of renal disease: a meta-analysis. (Kidney International)
  7. Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
  8. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. (Journal of the American Medical Association (JAMA))
  9. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
  10. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)

Their papers